1. Home
  2. AMPH vs ELME Comparison

AMPH vs ELME Comparison

Compare AMPH & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • ELME
  • Stock Information
  • Founded
  • AMPH 1996
  • ELME 1960
  • Country
  • AMPH United States
  • ELME United States
  • Employees
  • AMPH N/A
  • ELME N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • ELME Real Estate Investment Trusts
  • Sector
  • AMPH Health Care
  • ELME Real Estate
  • Exchange
  • AMPH Nasdaq
  • ELME Nasdaq
  • Market Cap
  • AMPH 1.1B
  • ELME 1.3B
  • IPO Year
  • AMPH 2014
  • ELME N/A
  • Fundamental
  • Price
  • AMPH $23.30
  • ELME $15.75
  • Analyst Decision
  • AMPH Hold
  • ELME Hold
  • Analyst Count
  • AMPH 5
  • ELME 6
  • Target Price
  • AMPH $38.00
  • ELME $17.80
  • AVG Volume (30 Days)
  • AMPH 566.0K
  • ELME 591.9K
  • Earning Date
  • AMPH 05-07-2025
  • ELME 05-01-2025
  • Dividend Yield
  • AMPH N/A
  • ELME 4.58%
  • EPS Growth
  • AMPH N/A
  • ELME N/A
  • EPS
  • AMPH 2.77
  • ELME N/A
  • Revenue
  • AMPH $730,659,000.00
  • ELME $243,915,000.00
  • Revenue This Year
  • AMPH $1.48
  • ELME $4.52
  • Revenue Next Year
  • AMPH $5.97
  • ELME $2.58
  • P/E Ratio
  • AMPH $8.47
  • ELME N/A
  • Revenue Growth
  • AMPH 8.05
  • ELME 5.31
  • 52 Week Low
  • AMPH $22.64
  • ELME $13.95
  • 52 Week High
  • AMPH $53.96
  • ELME $18.49
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 39.25
  • ELME 47.05
  • Support Level
  • AMPH $23.30
  • ELME $15.74
  • Resistance Level
  • AMPH $25.36
  • ELME $16.30
  • Average True Range (ATR)
  • AMPH 0.86
  • ELME 0.40
  • MACD
  • AMPH 0.10
  • ELME 0.06
  • Stochastic Oscillator
  • AMPH 1.66
  • ELME 56.69

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

Share on Social Networks: